Mobile App

Google Play Apple Store
Quarterly Brief (April-June 2021): A Current Expert Analysis on Important HIV Clinical Decisions
AMA/ANCC/ACPE Activities
New frontiers for HIV therapy continue to be explored, as underscored by the clinical development and use of new agents, changing regimen strategies and development of long-acting novel agents. This expanding era of simplified and effective HIV therapy presents physicians with many new opportunities and challenges for providing care. To deliver state-of-the-art HIV prevention and care, healthcare providers must stay informed regularly of new clinical data and treatment recommendations in HIV.

This educational Quarterly Brief, covering HIV data from April through June of 2021 will discuss the most clinically relevant information including HIV mortality, COVID-19, ART guidelines and recent studies, weight gain and PrEP.
Review the activity and claim AMA, ANCC or ACPE credit/contact hour after completion of a brief pretest and posttest/evaluation.
 












Faculty Chair
Paul Sax, MD Paul Sax, MD
Clinical Director
Division of Infectious Diseases
Brigham and Women’s Hospital
Professor of Medicine
Harvard Medical School
Faculty
Laila Woc-Colburn, MD Laila Woc-Colburn, MD
Associate Professor
Division of Infectious Diseases
Emory School of Medicine Division
 

20
Supported by an independent educational grant from ViiV Healthcare

Launch Date: July 27, 2021
Release Date: July 27, 2021
Expiration Date: June 30, 2022

June 30, 2022
Mini Module
7148
QuarterlyBrief_WebBanner_1158.gif
HIV